2026 SNMMI MID-WINTER MEETING
Isotope Production/Supply:
Domestic Isotope Availability Policy Statement - 2018
SNMMI Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients - 2025
Joint Position Statements and Documents:
SIR, ACR, SNMMI Position Statement on Selective Internal Radiation Therapy (SIRT) with Yttrium-90 (Y-90) - 2024
SNMMI, ACR, ASTRO, AAPM Nuclear Medicine Clarification Act Opposition Letter - 2025
Comment Letters:
SNMMI Comments on NRC Draft Regulatory Guide DG-8061, Release of Patients Administered Radioactive Materials - 2023
SNMMI Comments on CY25 Hospital Outpatient Prospective Payment Proposed Rule - 2024
SNMMI Comments on CY25 Medicare Physician Fee Schedule Payment Policies - 2024
SNMMI Comments on USP/NF PF 49(5) (823) - 2024
SNMMI Comments on CY26 Hospital Outpatient Prospective Payment Proposed Rule - 2025
SNMMI Comments on CY25 Medicare Physician Fee Schedule Payment Policies - 2025
SNMMI Comments on FDA's "Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development" - 2025
SNMMI Comments on Diagnostic Imaging Interoperability Standards and Certification, RIN 0955-AA11 - 2026
State Letters: